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A Consortium Approach to Building a Recovery-ready Community in Tooele
County, Utah
Maren Wright Voss, Gabriele Ciciurkaite, Erin Fanning Madden, Katie Zaman, Sandra H. Sulzer
Abstract
Substance Use Disorder (SUD) remains a critical issue in rural and tribal populations of Utah.
In response, we created a consortium of recovery programs, tribal partners, social scientists,
substance use disorders counselors, and treatment specialists to target prevention, treatment and
recovery programming efforts in Tooele County, Utah.
Introduction
Substance Use Disorder (SUD) is a persistent problem in Tooele County, Utah. Tooele county’s
drug overdose death rate between 2015 and 2019 was 21 per 100,000 people, which is higher the
statewide rate of approximately 20 per 100,000 people (Centers for Disease Control and
Prevention, 2020). In addition to high fatal and non-fatal overdose rates, Tooele County lacks a
adequately specialized trained workforce necessary for meeting SUD treatment needs and
recovery support services to reduce harms associated with opioid use disorder (OUD) and other
substance use issues (DasGupta, et al., 2020; Canary et al., 2017). To address these challenges,
USU Extension received funding from the Health Resources and Services Administration
(HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award
totaling $1,000,000, and initiated a consortium between state, country and local partners to
implement prevention, treatment and recovery activities.
The selected strategies were adopted based on a review of effective interventions for addressing
substance use. For example, individuals who are trained on how to use naloxone are more likely
to know how to reduce their risk of overdose, and are less likely to die from an overdose
(Katzman et al., 2018; Seal et al., 2001; Tobin et al., 2005; Walley et al., 2013). There is a 96%
opioid overdose survival rate during layperson naloxone administration (Bennett et al., 2011).
Stigma around opioid overdoses negatively affects the mental health of individuals who use
drugs (Hatzenbuehler et al., 2013), and stigma reduction has been shown to facilitate treatment
adherence and recovery (Versfeld, et al., 2020). Geographic areas with fewer providers offering
medication treatment for opioid use disorder (MOUD) also have higher rates of overdose deaths
(Rigg et al., 2018, Jones et al, 2018.)
Response
With grant funding from the HHS, we designed a culturally responsive and multi-pronged
community approach to tackle SUD in Tooele county. We focused on stigma reduction (i.e.,
community awareness campaigns and harm reduction trainings for professionals), expanded
SUD work-force capacity (i.e., para-professional certifications and funding), and increased
community-level support for persons in recovery (i.e., shared community events, economic aid,
and naloxone distribution).
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Target Populations
The multi-pronged approach served several target populations. Community members and
professionals impacted by stigma received substance use education and harm reduction trainings.
Individuals in recovery with insufficient support received access to emergency recovery financial
aid for treatment costs, transportation, childcare, and housing expenses. Agencies with an
inadequate workforce received access to coalition resources, professional development support,
and para-professional workforce funding.
Program Outcomes and Impacts
During the first 24 months of project implementation, multiple activities provided sustained
prevention, treatment and recovery services. The outcomes of the consortium include an increase
in collaboration, care providers focused on SUDs, and stigma reduction.
Increase in Collaboration: Consortium membership increased in size and diversity – from four
(4) organizations to fifteen (15), and a doubling membership of Recovery Community
Organizations (RCOs). This resulted in expansion of services such as gas card support for
treatment access, and funding the planning phase for a crisis nursery and a methadone clinic.
Enhanced collaboration was evidenced throughout consortium activities. For example,
community recovery event sponsorship increased from 10 in year one, to 30 community agencies
in year two.
Increase in Care Providers Addressing SUDs: Associated with our efforts, the number of
Tooele County physicians to treat opioid use disorder with FDA-approved buprenorphine
medication increased by 40% (from 5 to 7) during the first year of our project with a $200
federally funded training stipend. Additionally, we created a database of 105 opioid prescribing
providers, which will be used to promote controlled substance database (CSD) utilization and
pain management training. When waiver training requirements shifted in 2021, an additional
eight providers received MOUD training.
Stigma Reduction: The consortium compiled a stigma reduction resource booklet for healthcare
providers and community members, which includes evidence-based information on safe opioid
use, prescribing guidelines, and treatment and harm reduction resources for people with
SUD/OUD. Stigma reduction trainings were held at 11 community agencies and 1,100 resource
guides have been distributed at 25 training and community events.
Survey results from stigma reduction trainings showed increased support for MOUD (methadone
and buprenorphine) and harm reduction interventions. Findings show there was a large increase
in support from public attendees for harm reduction interventions. Table 1 shows the pre-post
change in attitudes on several markers of harm reduction acceptance (n = 21).
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Table 1. Changes in participants’ perception toward harm reduction methods after the training.
% in Agreement
Statement
Before
After
Training Training
Methadone is a legitimate and effective medicine for treating opioid
43%
90%
addiction.
Buprenorphine (often known by its brand names, “Suboxone” or
48%
90%
“Subutex”) is a legitimate and effective medicine for treating opioid
addiction.
Naloxone (often known by its brand name, “Narcan”), which is an
71%
100%
opioid overdose reversal drug, is an effective medicine for preventing
deaths due to opioid overdose.
I would be OK if Naloxone was distributed in my place of work.
71%
100%
Harm reduction programs, such as syringe distribution programs and
48%
100%
safe drug consumption facilities, help people who use drugs to begin
to improve their health and can encourage such individuals to
eventually engage in treatments like methadone and counseling.
Increase in Naloxone Access: We distributed 79 naloxone kits directly to community members
and 660 naloxone kits to community agencies and consortium partners. We also surveyed local
pharmacies and found that the majority of Tooele pharmacies carry naloxone and sell it without
requiring a prescription. About half of pharmacy staff reported willingness to receive additional
training on opioid overdose reversal.
Public Value and Next Steps
Our project created a space for Tooele County providers and community members to collaborate
on building a recovery-ready community. Our efforts to date have resulted in identification of
needs and gaps in services and preliminary efforts to address these gaps with evidence-based
strategies for prevention, treatment, and recovery. Facilitated by our consortium, coordination
and collaboration has resulted in improved access to, and availability of services for people with
SUDs in Tooele County. These efforts are necessary in reducing the harms and mortality
associated with SUDs.
There is more to be done to address the needs of people with SUDs. We continue to develop our
consortium’s capacity to collaborate with other relevant organizations on this persistent problem
to serve more people. Stigma towards people with SUDs, by both the general public and health
care providers, remains a substantial barrier. We continue to work to develop a professional
workforce trained in harm reduction, and to create bridges to services for Tooele community
members. Our current efforts include bringing new partners into our consortium, such as faithbased organizations, criminal justice and law enforcement, and the local mental health authority.
By building the capacity of local community organizations and institutions, the outcomes of this
program will persist long after the end of funding.
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